Walmart Limiting Opioid Prescription Stock To Strict 7-Day Supply In-Store

Shutterstock

Shutterstock

The CDC says that prescriptions for acute pain should be targeted in the fight against the opioid epidemic because "long-term opioid use often begins with treatment of acute pain".

The innovative disposal solution will now be provided in addition to ongoing counseling available to Walmart patients on proper opioid use when filling an opioid prescription at any one of its 4,700 pharmacies nationwide.

Doctors and pharmacies are strengthening opioid policies following a suggestion to do so by the Centers for Disease Control and Prevention in 2016.

Additionally, from January 20 20, Walmart pharmacies may require e-prescriptions for controlled substances, as they have "recognized to become prone to errors, they can not be changed or copied and so are trackable".

They said that e-prescriptions are proven to be less prone to errors and cannot be altered or copied, and they can be tracked electronically.

The restrictions apply to all Walmart pharmacies and its Sam's Club unit in the US and Puerto Rico. Aetna said in December it would waive copays for Narcan, a brand name for the opioid overdose-reversal medication naloxone, and would limit first-time opioid prescriptions.

In other new efforts to combat the opioid epidemic, Walmart is ensuring that its pharmacists make naloxone recommendations for patients who might be at risk for overdose. Patients with chronic Class II opioid prescriptions will receive the packet every six months.

Additional training and education on opioid stewardship for pharmacists, including a pain management curriculum. But unlike Walmart's NarxCare, the prescription drug monitoring programs are limited to the boundaries of each state. Walmart shares are down 2.1% in Monday trading, and down 13.2% for the year to date. Walmart continues to be a leader in sustainability, corporate philanthropy and employment opportunity.

Latest News